共 13 条
[1]
Querol-Ribelles J.M., Tenias J.M., Querol-Borras J.M., Gonzalez-Granda D., Hernandez M., Ferreruela R., Martinez I., Validación del Pneumonia Severity Index en la hospitalizació n de los pacientes con neumonía adquirida en la comunidad, Medicina Clinica, 122, 13, pp. 481-486, (2004)
[2]
Bauer T.T., Ewig S., Marre R., Suttorp N., Welte T., CRB-65 predicts death from community-acquired pneumonia, Journal of Internal Medicine, 260, 1, pp. 93-101, (2006)
[3]
Almirall J., Bolibar I., Toran P., Pera G., Boquet X., Balanzo X., Sauca G., Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia, Chest, 125, 4, pp. 1335-1342, (2004)
[4]
Masia M., Gutierrez F., Shum C., Padilla S., Navarro J.C., Flores E., Hernandez I., Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index, Chest, 128, 4, pp. 2223-2229, (2005)
[5]
Yende S., Tuomanen E.I., Wunderink R., Kanaya A., Newman A.B., Harris T., De Rekeneire N., Kritchevsky S.B., Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia, American Journal of Respiratory and Critical Care Medicine, 172, 11, pp. 1440-1446, (2005)
[6]
Christ-Crain M., Morgenthaler N.G., Stolz D., Muller C., Bingisser R., Harbarth S., Tamm M., Struck J., Bergmann A., Muller B., Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397], Critical Care, 10, 3, (2006)
[7]
Huang D.T., Angus D.C., Kellum J.A., Pugh N.A., Weissfeld L.A., Struck J., Delude R.L., Rosengart M.R., Yealy D.M., Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia, Chest, 136, pp. 823-831, (2009)
[8]
Christ-Crain M., Morgenthaler N.G., Struck J., Harbarth S., Bergmann A., Muller B., Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: An observational study, Crit Care, 9, pp. 18816-18824, (2005)
[9]
Gegenhuber A., Struck J., Dieplinger B., Poelz W., Pacher R., Morgenthaler N.G., Bergmann A., Haltmayer M., Mueller T., Comparative Evaluation of B-Type Natriuretic Peptide, Mid-Regional Pro-A-type Natriuretic Peptide, Mid-Regional Pro-Adrenomedullin, and Copeptin to Predict 1-Year Mortality in Patients With Acute Destabilized Heart Failure, Journal of Cardiac Failure, 13, 1, pp. 42-49, (2007)
[10]
Hirata Y., Mitaka C., Sato K., Nagura T., Tsunoda Y., Amaha K., Marumo F., Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis, Journal of Clinical Endocrinology and Metabolism, 81, 4, pp. 1449-1453, (1996)